Fundz

VahatiCor

Santa Clara, California, United States · Biotechnology, Health Care, Medical · 15 employees

VahatiCor is a medtech company dedicated to transforming cardiac care for Coronary Microvascular Dysfunction (CMD). They are focused on developing innovative therapies, particularly the A-FLUX Reducer System®, which aims to enhance myocardial perfusion and relieve symptoms of angina for millions affected by CMD. The company is currently advancing clinical studies and preparing for pivotal trials t

Funding history

  • Funding Round — $21.2M — Dec 2025
  • Series series b — $23.0M — Nov 2025

Recent signals

  • May 18, 2026: VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer
  • Dec 04, 2025: Raised $21.2M
  • Nov 18, 2025: Raised $23.0M in Series series b

See plans & pricing → Track VahatiCor’s funding, hiring, and signals — with verified contacts — on Fundz.